Johnson & Johnson's (JNJ +0.5%) subsidiary Alza Corp. and Janssen Pharmaceutica NV agree to...

|About: Johnson & Johnson (JNJ)|By:, SA News Editor

Johnson & Johnson's (JNJ +0.5%) subsidiary Alza Corp. and Janssen Pharmaceutica NV agree to transfer world-wide rights for the premature ejaculation treatment Priligy to drug developer Furiex Pharmaceuticals (FURX +9.3%).